Market Size of Arteriotomy Closure Devices Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 6.60 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Arteriotomy Closure Devices Market Analysis
The arteriotomy closure devices market is expected to register a CAGR of 6.6% over the forecast period.
The COVID-19 outbreak impacted the market as the rate of vascular diseases significantly increased during the pandemic. For instance, as per the study published in WebMD in March 2022, people who contracted COVID-19 were at a higher risk for 20 different heart and vascular diseases after being infected. The study also stated that 20 heart disorders were diagnosed in patients who suffered from long-term COVID-19 disease. Arteriotomy closure devices are widely used to decrease vascular complications and reduce the time to hemostasis and ambulation. Therefore, increasing cases of vascular diseases indicate that there was an increased demand for arteriotomy closure devices, owing to which the market witnessed considerable growth during the pandemic. Although the COVID-19 outbreak severely impacted the market, it is expected to recover in the post-pandemic era to post-strong growth.
The rising geriatric population is the major factor driving the market's growth. For instance, as per the report published by the National Commission on Population in India in July 2021, it was estimated that around 138.0 million elderly persons were living in India in 2021, of which 67.0 million were males, and 71.0 million were females. The report also stated that the growth rate of the elderly population was higher than that of the general population, and the elderly population has grown by 36.0% in the last two decades. Similarly, according to the research study published in December 2021, the overall self-reported prevalence of diagnosed cardiovascular diseases (CVDs) was 29.4% for older persons of age 45 and over, and the prevalence rate rose with age, from 22.0% in the 45-54 age group to 38.0% in the 70+ age group which shows that the geriatric population is at high risk of having cardiovascular diseases Thus, increasing geriatric population is one of the major factors for increasing the prevalence rate of cardiovascular diseases. Therefore, considerable market growth is anticipated over the forecast period.
However, the high cost of the devices may likely hinder the market's growth over the forecast period.
Arteriotomy Closure Devices Industry Segmentation
As per the scope of the report, arteriotomy closure devices (ACD) are widely used by surgeons to perform both diagnostic and interventional procedures. ACDs are of two types: active closure devices (collagen plugs, suture devices, and clips) and passive closure devices (compression devices and hemostasis pads). These closure devices are used to achieve hemostasis, improve patient outcomes, and decrease vascular complications and hospitalization rates. Arterial access is usually obtained at the common femoral or radial artery.
The arteriotomy closure devices market is segmented by product (active closure devices and passive closure devices), application (femoral arterial access procedures and radial arterial access procedures), end user (hospitals, ambulatory care centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
By Product | |
Active Closure Devices | |
Passive Closure Devices |
By Application | |
Femoral Arterial Access Procedures | |
Radial Arterial Access Procedures |
By End User | |
Hospitals | |
Ambulatory Care Centers | |
Other End Users |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Arteriotomy Closure Devices Market Size Summary
The arteriotomy closure devices market is poised for significant growth, driven by the increasing prevalence of vascular diseases and the rising geriatric population. The COVID-19 pandemic has underscored the importance of these devices, as it led to a surge in vascular complications among infected individuals, thereby boosting demand. Arteriotomy closure devices play a crucial role in minimizing vascular complications and expediting recovery times, which has been particularly beneficial during the pandemic. The market is expected to recover and expand in the post-pandemic period, supported by the growing elderly population, which is more susceptible to cardiovascular diseases. This demographic shift is particularly pronounced in regions like Asia-Pacific, where the elderly population is projected to grow significantly, further driving the demand for advanced medical interventions.
North America is anticipated to experience robust growth in the arteriotomy closure devices market, fueled by the high incidence of cardiovascular diseases and a substantial elderly population. The region's market expansion is supported by key product launches, strategic partnerships, and a concentration of major industry players. The competitive landscape is characterized by the presence of prominent companies such as Abbott Laboratories, Terumo Corporation, and Medtronic PLC, among others. These companies are actively engaged in product innovation and regulatory approvals to enhance their market presence. Despite the high cost of these devices posing a potential challenge, the overall market outlook remains positive, with ongoing advancements in medical technology and increasing awareness of cardiovascular health contributing to sustained growth.
Arteriotomy Closure Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Incidences of Vascular Disorders
-
1.2.2 Rising Geriatric Population
-
-
1.3 Market Restraints
-
1.3.1 High Cost of the Device
-
1.3.2 Risk Associated With the Procedure
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
2.1 By Product
-
2.1.1 Active Closure Devices
-
2.1.2 Passive Closure Devices
-
-
2.2 By Application
-
2.2.1 Femoral Arterial Access Procedures
-
2.2.2 Radial Arterial Access Procedures
-
-
2.3 By End User
-
2.3.1 Hospitals
-
2.3.2 Ambulatory Care Centers
-
2.3.3 Other End Users
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Arteriotomy Closure Devices Market Size FAQs
What is the current Arteriotomy Closure Devices Market size?
The Arteriotomy Closure Devices Market is projected to register a CAGR of 6.60% during the forecast period (2024-2029)
Who are the key players in Arteriotomy Closure Devices Market?
Teleflex Incorporated, Medtronic PLC, Merit Medical, Otsuka Medical Devices Co. Ltd (Veryan Medical) and Cardinal Health (Cordis) are the major companies operating in the Arteriotomy Closure Devices Market.